esbriet looks to fill unmet need in ipf treatment
Published 8 years ago • 2.5K plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
9:12
identifying patient populations for esbriet use
-
3:44
bc - the case for access to ipf treatments 1080p
-
4:16
patients with ipf have first signs of hope with approval of new medication
-
50:52
meeting the unmet needs of ipf patients
-
0:46
understanding idiopathic pulmonary fibrosis: making ipf easy to understand #shorts
-
6:01
ipf patients need your support
-
0:51
the unpredictability of idiopathic pulmonary fibrosis #palliativecare
-
3:15
ers vision - unmet needs in diagnosis and treatment of copd
-
17:30
about ipf (idiopathic pulmonary fibrosis) and uip (usual interstitial pneumonia)
-
24:16
s1 episode 2: idiopathic pulmonary fibrosis: who gets an antifibrotic?
-
22:35
integration of telomere length & mutations on treatment & transplant responses in pf | imre noth, md
-
24:15
idiopathic pulmonary fibrosis- ats/ers/jrs/alat update 2022
-
1:03
what happens to the lungs in ipf?
-
1:11
how is ipf diagnosed?
-
1:16
new ipf clinical trial: inhaled treprostinil for idiopathic pulmonary fibrosis
-
0:55
did you know… treatments to reduce pulmonary exacerbations remain a key unmet need in cf?
-
3:25
addressing unmet clinical needs with sirolimus debs (europcr 2020)
-
0:45
pf from my pov: relying on the pulmonary fibrosis foundation
-
1:29
tests involved in idiopathic pulmonary fibrosis (ipf)